Price $27.75 |
Market Cap
830.8M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
5.21
|
P/S
4.42
|
Dividend %
-
|
|
P/CF
377.2
|
P/FCF
-
|
Op. Cash Flow
-8.8K
|
FCF
-0.4
|
|
Op. Margin
-13.70%
|
Net Margin
-14.90%
|
ROE
-16.90%
|
ROI
-12.00%
|
|
ROA
-10.00%
|
EPS Growth
22.60%
|
Current Ratio
2.6
|
Debt/Equity
22.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Misonix, Inc. (MSON) | $13.45 | - | - | 114.7M | Strong Buy |
| Endo International PLC (ENDP) | $9.48 | - | - | 1.41B | Strong Buy |
| NeoGenomics, Inc. (NEO) | $14.05 | - | - | 935.2M | Strong Buy |
| China Health Industries Holdin (CHHE) | $0.86 | - | - | 55.7M | Strong Buy |
| Nature's Sunshine Prod. (NATR) | $9.25 | - | 4.40% | 172.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
